Creative Planning Becton Dickinson & CO Transaction History

Creative Planning

  • $103 Billion
  • Q4 2024

A detailed history of Creative Planning transactions in Becton Dickinson & CO stock. As of the latest transaction made, Creative Planning holds 54,298 shares of BDX stock, worth $12.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
54,298
Previous 47,387 14.58%
Holding current value
$12.2 Million
Previous $11.4 Million 7.82%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$220.02 - $243.75 $1.52 Million - $1.68 Million
6,911 Added 14.58%
54,298 $12.3 Million
Q3 2024

Oct 11, 2024
SELL
$221.47 - $242.41 $70,427 - $77,086
-318 Reduced 0.67%
47,387 $11.4 Million
Q2 2024

Aug 15, 2024
BUY
$225.07 - $246.17 $520,811 - $569,637
2,314 Added 5.1%
47,705 $11.1 Million
Q1 2024

May 10, 2024
BUY
$233.45 - $247.73 $98,282 - $104,294
421 Added 0.94%
45,391 $11.2 Million
Q4 2023

Feb 14, 2024
SELL
$232.24 - $267.23 $393,879 - $453,222
-1,696 Reduced 3.63%
44,970 $11 Million
Q3 2023

Nov 16, 2023
BUY
$254.9 - $283.59 $117,254 - $130,451
460 Added 1.0%
46,666 $12.1 Million
Q2 2023

Jul 21, 2023
BUY
$238.39 - $265.32 $1.02 Million - $1.14 Million
4,296 Added 10.25%
46,206 $12.2 Million
Q1 2023

May 15, 2023
SELL
$229.71 - $259.35 $225,115 - $254,163
-980 Reduced 2.28%
41,910 $10.4 Million
Q4 2022

Feb 10, 2023
BUY
$218.29 - $256.91 $638,716 - $751,718
2,926 Added 7.32%
42,890 $10.9 Million
Q3 2022

Nov 03, 2022
SELL
$51.03 - $264.23 $79,964 - $414,048
-1,567 Reduced 3.77%
39,964 $8.91 Million
Q2 2022

Aug 15, 2022
BUY
$234.74 - $275.42 $1.05 Million - $1.23 Million
4,482 Added 12.1%
41,531 $10.2 Million
Q1 2022

May 16, 2022
BUY
$243.64 - $270.48 $439,282 - $487,675
1,803 Added 5.12%
37,049 $9.86 Million
Q4 2021

Feb 11, 2022
SELL
$230.08 - $250.94 $366,287 - $399,496
-1,592 Reduced 4.32%
35,246 $8.86 Million
Q3 2021

Nov 10, 2021
BUY
$232.72 - $256.47 $138,701 - $152,856
596 Added 1.64%
36,838 $9.06 Million
Q2 2021

Aug 04, 2021
SELL
$232.65 - $254.58 $236,139 - $258,398
-1,015 Reduced 2.72%
36,242 $8.81 Million
Q1 2021

Apr 30, 2021
SELL
$232.09 - $256.88 $5,802 - $6,422
-25 Reduced 0.07%
37,257 $9.06 Million
Q4 2020

Jan 29, 2021
BUY
$221.92 - $245.94 $367,499 - $407,276
1,656 Added 4.65%
37,282 $9.33 Million
Q3 2020

Nov 05, 2020
BUY
$215.77 - $276.76 $752,821 - $965,615
3,489 Added 10.86%
35,626 $8.29 Million
Q2 2020

Jul 23, 2020
SELL
$219.9 - $263.41 $116,986 - $140,134
-532 Reduced 1.63%
32,137 $7.69 Million
Q1 2020

May 05, 2020
SELL
$195.69 - $279.01 $445,194 - $634,747
-2,275 Reduced 6.51%
32,669 $7.51 Million
Q4 2019

Jan 30, 2020
BUY
$236.45 - $266.82 $137,613 - $155,289
582 Added 1.69%
34,944 $9.5 Million
Q3 2019

Nov 01, 2019
BUY
$230.58 - $256.08 $417,119 - $463,248
1,809 Added 5.56%
34,362 $8.69 Million
Q2 2019

Jul 26, 2019
SELL
$217.4 - $246.08 $198,921 - $225,163
-915 Reduced 2.73%
32,553 $8.2 Million
Q1 2019

Apr 24, 2019
SELL
$206.05 - $248.17 $667,189 - $803,574
-3,238 Reduced 8.82%
33,468 $8.36 Million
Q4 2018

Feb 01, 2019
BUY
$204.73 - $257.93 $256,731 - $323,444
1,254 Added 3.54%
36,706 $8.27 Million
Q3 2018

Oct 25, 2018
BUY
$233.07 - $256.0 $178,065 - $195,584
764 Added 2.2%
35,452 $9.25 Million
Q2 2018

Jul 20, 2018
BUY
$208.1 - $233.85 $54,106 - $60,801
260 Added 0.76%
34,688 $8.31 Million
Q1 2018

Apr 18, 2018
BUY
$205.46 - $240.27 $1.16 Million - $1.35 Million
5,635 Added 19.57%
34,428 $7.46 Million
Q4 2017

Jan 17, 2018
BUY
$189.0 - $222.64 $282,177 - $332,401
1,493 Added 5.47%
28,793 $6.16 Million
Q3 2017

Oct 17, 2017
BUY
$186.89 - $198.9 $5.1 Million - $5.43 Million
27,300
27,300 $5.35 Million

Others Institutions Holding BDX

# of Institutions
1,803
Shares Held
260M
Call Options Held
1.27M
Put Options Held
1.09M
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email